YAP1 recruits c-Abl to protect angiomotin-like 1 from Nedd4-mediated degradation

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Skouloudaki, Kassiani ^a,c   Walz, Gerd ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; ANGIOMOTIN LIKE 1 PROTEIN; PDZ PROTEIN; PROTEASOME; PROTEIN ZO1; TRANSCRIPTION FACTOR YAP1; UBIQUITIN PROTEIN LIGASE NEDD4; UNCLASSIFIED DRUG; AMOTL1 PROTEIN, HUMAN; ESCRT PROTEIN; MEMBRANE PROTEIN; NEDD4 UBIQUITIN PROTEIN LIGASES; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SMALL INTERFERING RNA; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; YAP1 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS; TIGHT JUNCTION; UBIQUITINATION; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CYTOLOGY; DOG; EPITHELIUM CELL; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; DOGS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-ABL; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS; TRANSFECTION; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84860484234     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035735     Document Type: Article

References (39)

1. Zhao B, Li L, Lu Q, Wang LH, Liu CY, et al. (2011) Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 25: 51-63.
2. Wullschleger S, Loewith R, Hall MN, (2006) TOR signaling in growth and metabolism. Cell 124: 471-484.
3. Harvey K, Tapon N, (2007) The Salvador-Warts-Hippo pathway- an emerging tumour-suppressor network. Nat Rev Cancer 7: 182-191.
4. Pan D, (2007) Hippo signaling in organ size control. Genes Dev 21: 886-897.
5. Saucedo LJ, Edgar BA, (2007) Filling out the Hippo pathway. Nat Rev Mol Cell Biol 8: 613-621.
6. Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, et al. (2006) Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci U S A 103: 12405-12410.
7. Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, et al. (2006) Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125: 1253-1267.
8. Dong J, Feldmann G, Huang J, Wu S, Zhang N, et al. (2007) Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130: 1120-1133.
9. Zhao B, Wei X, Li W, Udan RS, Yang Q, et al. (2007) Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21: 2747-2761.
10. Chen CL, Gajewski KM, Hamaratoglu F, Bossuyt W, Sansores-Garcia L, et al. (2010) The apical-basal cell polarity determinant Crumbs regulates Hippo signaling in Drosophila. Proc Natl Acad Sci U S A 107: 15810-15815.
11. Grzeschik NA, Parsons LM, Allott ML, Harvey KF, Richardson HE, (2010) Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms. Curr Biol 20: 573-581.
12. Robinson BS, Huang J, Hong Y, Moberg KH, (2010) Crumbs regulates Salvador/Warts/Hippo signaling in Drosophila via the FERM-domain protein Expanded. Curr Biol 20: 582-590.
13. Skouloudaki K, Puetz M, Simons M, Courbard JR, Boehlke C, et al. (2009) Scribble participates in Hippo signaling and is required for normal zebrafish pronephros development. Proc Natl Acad Sci U S A 106: 8579-8584.
14. Matter K, Aijaz S, Tsapara A, Balda MS, (2005) Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Curr Opin Cell Biol 17: 453-458.
15. Bratt A, Wilson WJ, Troyanovsky B, Aase K, Kessler R, et al. (2002) Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains. Gene 298: 69-77.
16. Gagne V, Moreau J, Plourde M, Lapointe M, Lord M, et al. (2009) Human angiomotin-like 1 associates with an angiomotin protein complex through its coiled-coil domain and induces the remodeling of the actin cytoskeleton. Cell Motil Cytoskeleton 66: 754-768.
17. Sugihara-Mizuno Y, Adachi M, Kobayashi Y, Hamazaki Y, Nishimura M, et al. (2007) Molecular characterization of angiomotin/JEAP family proteins: interaction with MUPP1/Patj and their endogenous properties. Genes Cells 12: 473-486.
18. Wang W, Huang J, Chen J, (2010) Angiomotin-like Proteins Associate with and Negatively Regulate YAP1. J Biol Chem 286: 4364-4370.
19. Zhao B, Li L, Tumaneng K, Wang CY, Guan KL, (2010) A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 24: 72-85.
20. Rotin D, Kumar S, (2009) Physiological functions of the HECT family of ubiquitin ligases. Nat Rev Mol Cell Biol 10: 398-409.
21. Vecchione A, Marchese A, Henry P, Rotin D, Morrione A, (2003) The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptor. Mol Cell Biol 23: 3363-3372.
22. Lin CH, MacGurn JA, Chu T, Stefan CJ, Emr SD, (2008) Arrestin-related ubiquitin-ligase adaptors regulate endocytosis and protein turnover at the cell surface. Cell 135: 714-725.
23. Bhandari D, Robia SL, Marchese A, (2009) The E3 ubiquitin ligase atrophin interacting protein 4 binds directly to the chemokine receptor CXCR4 via a novel WW domain-mediated interaction. Mol Biol Cell 20: 1324-1339.
24. Nikko E, Sullivan JA, Pelham HR, (2008) Arrestin-like proteins mediate ubiquitination and endocytosis of the yeast metal transporter Smf1. EMBO Rep 9: 1216-1221.
25. Raikwar NS, Vandewalle A, Thomas CP, (2010) Nedd4-2 interacts with occludin to inhibit tight junction formation and enhance paracellular conductance in collecting duct epithelia. Am J Physiol Renal Physiol 299: F436-444.
26. Schlosser A, Vanselow JT, Kramer A, (2005) Mapping of phosphorylation sites by a multi-protease approach with specific phosphopeptide enrichment and NanoLC-MS/MS analysis. Anal Chem 77: 5243-5250.
27. Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C, et al. Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem 286: 7018-7026.
28. Fu X, Yucer N, Liu S, Li M, Yi P, et al. RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage. Proc Natl Acad Sci U S A 107: 4579-4584.
29. Chen HI, Sudol M, (1995) The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc Natl Acad Sci U S A 92: 7819-7823.
30. Chen HI, Einbond A, Kwak SJ, Linn H, Koepf E, et al. (1997) Characterization of the WW domain of human yes-associated protein and its polyproline-containing ligands. J Biol Chem 272: 17070-17077.
31. Pires JR, Taha-Nejad F, Toepert F, Ast T, Hoffmuller U, et al. (2001) Solution structures of the YAP65 WW domain and the variant L30 K in complex with the peptides GTPPPPYTVG, N-(n-octyl)-GPPPY and PLPPY and the application of peptide libraries reveal a minimal binding epitope. J Mol Biol 314: 1147-1156.
32. Kasanov J, Pirozzi G, Uveges AJ, Kay BK, (2001) Characterizing Class I WW domains defines key specificity determinants and generates mutant domains with novel specificities. Chem Biol 8: 231-241.
33. Patrie KM, (2005) Identification and characterization of a novel tight junction-associated family of proteins that interacts with a WW domain of MAGI-1. Biochim Biophys Acta 1745: 131-144.
34. Sudol M, (1994) Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product. Oncogene 9: 2145-2152.
35. Levy D, Adamovich Y, Reuven N, Shaul Y, (2008) Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol Cell 29: 350-361.
36. Ko HS, Lee Y, Shin JH, Karuppagounder SS, Gadad BS, et al. (2010) Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function. Proc Natl Acad Sci U S A 107: 16691-16696.
37. Zhao B, Li L, Lu Q, Wang LH, Liu CY, et al. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 25: 51-63.
38. Zheng Y, Vertuani S, Nystrom S, Audebert S, Meijer I, et al. (2009) Angiomotin-like protein 1 controls endothelial polarity and junction stability during sprouting angiogenesis. Circ Res 105: 260-270.
39. Zhao B, Lei QY, Guan KL, (2008) The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol 20: 638-646.